China Factory Stock CAS 2156-56-1 Sodium Dichloroacetate, Find details about China Sodium Dichloroacetate Price, Sodium Dichloroacetate Powder from Factory Stock CAS 2156-56-1 Sodium Dichloroacetate
Analysis item | Standard | Analysis results |
Appearance | White to light yellow crystalline powder | Off white powder |
Identification | IR spectra is consistent with CRS | Conforms |
Loss on drying | ≤0.5% | 0.002 |
PH | 7.0~9.0 | 8 |
Residue on ignition | ≤0.2% | 0.0001 |
Total impuriries | ≤0.5% | conforms |
Assay | 99.0%~101.0% | 0.998 |
Sodium Dichloroacetate, commonly referred to simply as dichloroacetate or DCA, is a buffered form of dichloracetic acid. This synthetic chemical compound has gained attention because it shows some potential as a cancer treatment. The buffered form of dichloracetic acid is not an acid and can be taken by mouth without causing burning. Sodium dichloroacetate is not approved drug and so is not readily available as a pharmaceutical-grade product. Consult with your doctor if you are interested in this potential treatment, which is still in the early research stages.
The only confirmed medical use for sodium dichloroacetate is for removing warts and other skin growths, according to the American Cancer Society. Researchers have tested it on humans for decreasing lactic acid buildup, or lactic acidosis, in rare diseases involving metabolism or caused by severe head injuries and malaria. Side effects have been a problem with this possible treatment.
Company information: